Publications

Cost-effectiveness of varicella and zoster vaccination in England&amp;Wales: importance measures for correlated parameters.

Bilcke, J; VAN HOEK, AJ; Hens, N; Aerts, M; EDMUNDS, WJ; Beutels, P;

2010

Procedia - Social and Behavioral Sciences, (2010).2 6 10.1016/j.sbspro.2010.05.142.

Invasive pneumococcal disease in Fiji: clinical syndromes, epidemiology, and the potential impact of pneumococcal conjugate vaccine.

Russell, FM; Carapetis, JR; Tikoduadua, L; Paeds, D; Chandra, R; Seduadua, A; Satzke, C; Pryor, J; Buadromo, E; Waqatakirewa, L; MULHOLLAND, EK;

2010

The Pediatric infectious disease journal, (2010).29 9 10.1097/INF.0b013e3181ec7ae2.

The role of adults in household outbreaks of pertussis.

Baptista, PN; Magalhães, VS; RODRIGUES, LC;

2010

International journal of infectious diseases, (2010).14 2 10.1016/j.ijid.2009.03.026.

Isolation of viable Plasmodium falciparum merozoites to define erythrocyte invasion events and advance vaccine and drug development.

Boyle, MJ; Wilson, DW; Richards, JS; Riglar, DT; TETTEH, KK A; CONWAY, DJ; Ralph, SA; Baum, J; Beeson, JG;

2010

Proceedings of the National Academy of Sciences of the United States of America, (2010).107 32 10.1073/pnas.1009198107.

A brief history of economic evaluation for human papillomavirus vaccination policy.

Beutels, P; JIT, M;

2010

Sexual health, (2010).7 3 10.1071/SH10018.

Public health response to influenza A(H1N1) as an opportunity to build public trust.

LARSON, HJ; HEYMANN, DL;

2010

JAMA, (2010).303 3 10.1001/jama.2009.2023.

Liposomal delivery of p-ialB and p-omp25 DNA vaccines improves immunogenicity but fails to provide full protection against B. melitensis challenge.

Commander, NJ; Brewer, JM; WREN, BW; Spencer, SA; Macmillan, AP; Stack, JA;

2010

Genetic vaccines and therapy, (2010).8 1 10.1186/1479-0556-8-5.

Safety and immunogenicity of the malaria vaccine candidate GMZ2 in malaria-exposed, adult individuals from Lambaréné, Gabon.

Mordmüller, B; Szywon, K; Greutelaers, B; Esen, M; Mewono, L; Treut, C; Mürbeth, RE; Chilengi, R; Noor, R; Kilama, WL; Imoukhuede, EB; Imbault, N; Leroy, O; Theisen, M; Jepsen, S; MILLIGAN, P; Fendel, R; Kremsner, PG; Issifou, S;

2010

Vaccine, (2010).28 41 10.1016/j.vaccine.2010.07.085.

A vaccine against malaria: a substantial step forward.

Moorthy, V; SMITH, PG; Kieny, M-P;

2009

Lancet, (2009).373 9673 10.1016/S0140-6736(09)60802-3.

Estimating the cost-effectiveness of vaccination against herpes zoster in England and Wales.

VAN HOEK, AJ; Gay, N; Melegaro, A; Opstelten, W; EDMUNDS, WJ;

2009

Vaccine, (2009).27 9 10.1016/j.vaccine.2008.12.024.